Xstelos Holdings, Inc. Receivables Turnover Ratio (XTLS), from the third quarter 2013 to the third quarter 2012 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xstelos Holdings, Inc.  (XTLS)
 

Xstelos Holdings Accounts Receivables Turnover Ratio from the third quarter 2013 to the third quarter 2012

Quarterly Results, Trends, Rankings, Statistics


Xstelos Holdings, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2013 to a ratio of 4.32, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2013. Average receivable collection period, for the Xstelos Holdings in Sep 30 2013 quarter, has decreased to 84 days, compared to 85 days, in the Jun 30 2013 quarter.

If we take a look into Healthcare sector 280 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2013 from 1242 to 3006.

What is Receivable Turnover Ratio?
What is Xstelos Holdings, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XTLS Receivables Turnover Ratio (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Receivable Change -6.26 % -14.33 % -21.1 % - -
Y / Y Revenue Change -3.46 % 12.94 % -21.12 % - -
Receivable Turnover Ratio (TTM) 4.32 4.28 4 4 3.62
XTLS's Total Ranking # 3006 # 1242 # 1242 # 1165 # 0
Accounts Receivable average collection period days 85 85 91 91 101
Seq. Receivable Change -3.36 % 16.33 % -21.52 % 6.25 % -11.67 %
Seq. Revenue Change -3.36 % 16.35 % -38.91 % 40.54 % 13.06 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 281
Overall Market # 3006

Receivable Turnover Ratio Statistics
High Average Low
0.26 0.24 0.24
  (Mar 31 2013)





XTLS Company Profile • Back to XTLS Efficiency Comparisons • Compare XTLS Receivables Turnover Ratio to its Competitors

Financial Statements
Xstelos Holdings's Accounts Receivable $ 6 Millions Visit XTLS's Balance sheet
Xstelos Holdings's Sales TTM $ 28 Millions Visit XTLS's Income Statement
Sources of XTLS's Revenues Visit XTLS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
XTLS's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
XTLS's Growth Rates XTLS's Roa XTLS's Inventory Turnover Ratio XTLS's Dividend Comparisons
XTLS's Profitability Ratios XTLS's Roi XTLS's Asset Turnover Ratio XTLS's Dividend Growth
XTLS's Valuation Ratios XTLS's Roe XTLS's Financial Strength Ratios XTLS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2013 Receivable at quarter ending Sep 30 2013
Soligenix inc   12.04 $ 4.058  Millions$ 0.337  Millions
Community Health Systems Inc   12.03 $ 26,322.962  Millions$ 2,188.565  Millions
Avid Bioservices Inc   11.89 $ 23.335  Millions$ 1.963  Millions
Statera Biopharma Inc fka Cytocom Inc   11.81 $ 6.778  Millions$ 0.574  Millions
Rockwell Medical inc   11.62 $ 51.415  Millions$ 4.423  Millions
Surmodics Inc   11.58 $ 56.132  Millions$ 4.849  Millions
Cadence Pharmaceuticals Inc  11.54 $ 94.417  Millions$ 8.183  Millions
China Biologic Products Holdings Inc   11.51 $ 194.760  Millions$ 16.922  Millions
Musclepharm Corporation  11.42 $ 89.877  Millions$ 7.869  Millions
Interpace Biosciences Inc   11.20 $ 150.060  Millions$ 13.395  Millions
Vycor Medical Inc   10.89 $ 1.075  Millions$ 0.099  Millions
Hca Healthcare Inc   10.69 $ 51,838.000  Millions$ 4,847.000  Millions
Lifeloc Technologies Inc   10.63 $ 7.916  Millions$ 0.745  Millions
Adynxx, Inc.  10.60 $ 1.729  Millions$ 0.163  Millions
Vivosim Labs Inc   10.54 $ 0.693  Millions$ 0.066  Millions
Apyx Medical Corp  10.51 $ 24.359  Millions$ 2.318  Millions
Novavax inc   10.41 $ 16.733  Millions$ 1.608  Millions
Immucell Corporation  10.27 $ 5.869  Millions$ 0.571  Millions
Amag Pharmaceuticals inc   9.97 $ 80.289  Millions$ 8.049  Millions
Genomic Health Inc  9.97 $ 253.202  Millions$ 25.396  Millions
Cutera Inc   9.76 $ 74.888  Millions$ 7.673  Millions
Seelos Therapeutics inc   9.76 $ 4.617  Millions$ 0.473  Millions
American Bio Medica Corporation  9.74 $ 9.064  Millions$ 0.931  Millions
Corindus Vascular Robotics, Inc.  9.73 $ 0.157  Millions$ 0.016  Millions
Biolife Solutions Inc   9.72 $ 8.709  Millions$ 0.896  Millions
Amedisys Inc  9.60 $ 1,318.719  Millions$ 137.437  Millions
National Healthcare Corp  9.57 $ 776.204  Millions$ 81.137  Millions
Adm Tronics Unlimited Inc   9.54 $ 1.515  Millions$ 0.159  Millions
Neurometrix Inc   9.47 $ 5.400  Millions$ 0.570  Millions
Immunogen inc   9.39 $ 48.662  Millions$ 5.183  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.